RFL Rafael Holdings, Inc.

NYSE
$0.92

Rafael Holdings, Inc. (RFL) is expected to report earnings on January 28, 2027, after the market close.

Rafael Reported Earnings
Thursday, October 29, 2026 · 8:00 AM ET
Earnings Date
Jan 28
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Rafael Holdings, Inc.

Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.